BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53
6858 results:

  • 1. [Incidence of common gene mutations in early-onset colorectal cancer and the association with cancer survival: a meta-analysis].
    Zhang RQ; Li SH; Hu TJ; Xu LY; Zhu YS; Li X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 May; 27(5):495-506. PubMed ID: 38778689
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. RAS/RAF mutations and microsatellite instability status in primary colorectal cancers according to HER2 amplification.
    Lee SM; Oh H
    Sci Rep; 2024 May; 14(1):11432. PubMed ID: 38763942
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Daunorubicin induces GLI1‑dependent apoptosis in colorectal cancer cell lines.
    Kim BR; Kim DY; Tran NL; Kim BG; Lee SI; Kang SH; Min BY; Hur W; Oh SC
    Int J Oncol; 2024 Jun; 64(6):. PubMed ID: 38757343
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Gene mutation profiling in microsatellite instability colorectal cancer and its association with the efficacy of immunotherapy: A retrospective study.
    Liu Y; Cui K; Ma W
    Cancer Med; 2024 May; 13(9):e6910. PubMed ID: 38746969
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells.
    Slaninová V; Heron-Milhavet L; Robin M; Jeanson L; Aissanou A; Kantar D; Tosi D; Bréhélin L; Gongora C; Djiane A
    BMC Cancer; 2024 May; 24(1):587. PubMed ID: 38741073
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Distinct Driver Pathway Enrichments and a High Prevalence of
    Tapia-Valladares C; Valenzuela G; González E; Maureira I; Toro J; Freire M; Sepúlveda-Hermosilla G; Ampuero D; Blanco A; Gallegos I; Morales F; Erices JI; Barajas O; Ahumada M; Contreras HR; González J; Armisén R; Marcelain K
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731914
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Spatial transcriptomic analysis reveals local effects of intratumoral fusobacterial infection on DNA damage and immune signaling in rectal cancer.
    Duggan WP; Kisakol B; Woods I; Azimi M; Dussmann H; Fay J; O'Grady T; Maguire B; Reynolds IS; Salvucci M; Slade DJ; McNamara DA; Burke JP; Prehn JHM
    Gut Microbes; 2024; 16(1):2350149. PubMed ID: 38709233
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Apoptotic effect of 5-fluorouracil-doxorubicin combination on colorectal cancer cell monolayers and spheroids.
    Bilgin S
    Mol Biol Rep; 2024 May; 51(1):603. PubMed ID: 38698270
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Identification and clinicopathological analysis of potential p73-regulated biomarkers in colorectal cancer via integrative bioinformatics.
    Bareja C; Dwivedi K; Uboveja A; Mathur A; Kumar N; Saluja D
    Sci Rep; 2024 Apr; 14(1):9894. PubMed ID: 38688978
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Detection and Significance of Molecular Markers in Immunotherapy and Targeted Therapy of colorectal cancer in Tibet].
    Luo HH; Liu BY; Huo Z; BIANbazhaxi ; Wang Q; DUObula ; NImazhuoma ; DA Z; Wang H; Guo PP
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2024 Apr; 46(2):184-192. PubMed ID: 38686714
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The Relationship of Microsatellite Instability with BRAF and p53 Mutations and Histopathological Parameters in colorectal Adenocarcinoma.
    Gündoğar Ö; Bektaş S; Yıldırım E; Gönüllü D
    Ann Ital Chir; 2024; 95(2):181-191. PubMed ID: 38684491
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Exploring the Key Signaling Pathways and ncRNAs in colorectal cancer.
    Lee YJ; Kim WR; Park EG; Lee DH; Kim JM; Shin HJ; Jeong HS; Roh HY; Kim HS
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674135
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Somatic Mutations in Surgically Treated colorectal Liver Metastases: An Overview.
    Wang J; Botvinov J; Bhatt AJ; Beyer K; Kreis ME; Adam M; Alseidi A; Margonis GA
    Cells; 2024 Apr; 13(8):. PubMed ID: 38667294
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Clinical impact of panel gene sequencing on therapy of advanced cancers of the digestive system: a retrospective, single center study.
    Dreikhausen L; Klupsch A; Wiest I; Xiao Q; Schulte N; Betge J; Boch T; Brochhausen C; Gaiser T; Hofheinz RD; Ebert M; Zhan T
    BMC Cancer; 2024 Apr; 24(1):526. PubMed ID: 38664720
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Discovery of WRN inhibitor HRO761 with synthetic lethality in MSI cancers.
    Ferretti S; Hamon J; de Kanter R; Scheufler C; Andraos-Rey R; Barbe S; Bechter E; Blank J; Bordas V; Dammassa E; Decker A; Di Nanni N; Dourdoigne M; Gavioli E; Hattenberger M; Heuser A; Hemmerlin C; Hinrichs J; Kerr G; Laborde L; Jaco I; Núñez EJ; Martus HJ; Quadt C; Reschke M; Romanet V; Schaeffer F; Schoepfer J; Schrapp M; Strang R; Voshol H; Wartmann M; Welly S; Zécri F; Hofmann F; Möbitz H; Cortés-Cros M
    Nature; 2024 May; 629(8011):443-449. PubMed ID: 38658754
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Mining and exploration of rehabilitation nursing targets for colorectal cancer.
    Li R; He J; Ni Z; Zhang J; Chi X; Kang C; Li Z; Li X
    Aging (Albany NY); 2024 Apr; 16(8):7022-7042. PubMed ID: 38637125
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Proteasome activation is critical for cell death induced by inhibitors of polo-like kinase 1 (PLK1) in multiple cancers.
    Wang Y; Wang G; Xiang W; Liu X; Jiang M; Hu J
    Eur J Pharmacol; 2024 Jun; 972():176558. PubMed ID: 38614382
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A role for RIO kinases in the crosshair of cancer research and therapy.
    Ghandadi M; Dobi A; Malhotra SV
    Biochim Biophys Acta Rev Cancer; 2024 May; 1879(3):189100. PubMed ID: 38604268
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Overcoming data scarcity in radiomics/radiogenomics using synthetic radiomic features.
    Ahmadian M; Bodalal Z; van der Hulst HJ; Vens C; Karssemakers LHE; Bogveradze N; Castagnoli F; Landolfi F; Hong EK; Gennaro N; Pizzi AD; Beets-Tan RGH; van den Brekel MWM; Castelijns JA
    Comput Biol Med; 2024 May; 174():108389. PubMed ID: 38593640
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Promising Anticancer Prodrugs Based on Pt(IV) Complexes with Bis-organosilane Ligands in Axial Positions.
    Navas F; Chocarro-Calvo A; Iglesias-Hernández P; Fernández-García P; Morales V; García-Martínez JM; Sanz R; De la Vieja A; García-Jiménez C; García-Muñoz RA
    J Med Chem; 2024 Apr; 67(8):6410-6424. PubMed ID: 38592014
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 343.